Bing Han
Bing Han publishes mostly in Surgery, Cardiology and Cardiovascular Medicine and Radiology, Nuclear Medicine and Imaging, on topics such as Cardiovascular Disease and Adiposity, Angiogenesis and VEGF in Cancer and Dermatologic Treatments and Research.
- World rank
- #6,426,100 of 7,710,434 ranked researchers
- Rank in China
- #884,925 of 978,568
- Works
- 22
- Citations
- 117
- Citations per work
- 5.3
What does Bing Han research?
Bing Han's work is mostly in Medicine (45%), Biochemistry, Genetics and Molecular Biology (6%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else1148.9%
- Health Sciences1045.4%
- Medicine1045.4%
- Life Sciences15.7%
- 1Surgery19% of their works
- 2Cardiology and Cardiovascular Medicine11% of their works
- 3Radiology, Nuclear Medicine and Imaging6% of their works
- 4Molecular Biology6% of their works
- 5Oncology6% of their works
- 6Psychiatry and Mental health4% of their works
Research topics
- Cardiovascular Disease and Adiposity
- Angiogenesis and VEGF in Cancer
- Dermatologic Treatments and Research
- Venous Thromboembolism Diagnosis and Management
- Peripheral Artery Disease Management
- Pharmacological Effects and Assays
- Microbial Metabolism and Applications
- Cancer-related molecular mechanisms research
Which keywords describe Bing Han's research?
The keywords of their largest research topics: Atherosclerosis, Risk Factors, Epicardial Fat, Perivascular Adipose Tissue, Antithrombotic Therapy, endothelial progenitor cells, Guidelines and Hypertrophic Scarring.
- Ractopamine
- Long Noncoding RNAs
- Cancer
- endothelial progenitor cells
- VEGF
- Keloids
- Guidelines
- Perivascular Adipose Tissue
- Risk Factors
- Atherosclerosis
- Epicardial Fat
- Antithrombotic Therapy
- Hypertrophic Scarring
- Peripheral Arterial Disease
- Venous Thromboembolism
- Biosynthesis
- Clenbuterol
- Microbial Pigments
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 18 words, with their numbers
- Atherosclerosis52 topics
- Risk Factors42 topics
- Epicardial Fat31 topic
- Perivascular Adipose Tissue31 topic
- Antithrombotic Therapy21 topic
- Guidelines21 topic
- Hypertrophic Scarring21 topic
- Keloids21 topic
- Peripheral Arterial Disease21 topic
- VEGF21 topic
- Venous Thromboembolism21 topic
- endothelial progenitor cells21 topic
- Biosynthesis11 topic
- Cancer11 topic
- Clenbuterol11 topic
- Long Noncoding RNAs11 topic
- Microbial Pigments11 topic
- Ractopamine11 topic
Where does Bing Han work?
Bing Han's main affiliation in the publication record is Baoding People's Hospital, China.
How many publications and citations does Bing Han have?
OpenAlex counts 22 works and 117 citations for Bing Han, an h-index of 6, ranking #6,426,100 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Other researchers named Bing Han
- bing-han-southeast-university
- bing-han-southern-university-of-science-and-technology
- bing-han-jilin-university
- bing-han-lanzhou-university
- bing-han-chinese-academy-of-sciences
- bing-han-zhengzhou-university-of-light-industry
- bing-han-university-of-toronto
- bing-han-rand-corporation
- bing-han-peking-university
- bing-han-shanghai-ninth-peoples-hospital
- bing-han-qingdao-university
- bing-han-xuzhou-central-hospital
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Bing Han. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.